XML 36 R26.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Note 8 - Financial Instruments With Off-balance-sheet Risk (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2022
Notes Tables |
Schedule of Fair Value, off-Balance-Sheet Risks [Table Text Block] |
|  | September 30, 2022 |
|  |  |  |  |  | Fair Value of |
|  |  |  |  |  | Unfunded |
|  | Principal |  |  | Commitment |
|  | Balance |  |  | Liability |
|  | (In thousands) |
Better Place Forests Co. |  | $ | 5,000 |  |  | $ | 6 |
BrightInsight, Inc. |  |  | 21,000 |  |  |  | 278 |
Britecore Holdings, Inc. |  |  | 5,000 |  |  |  | 66 |
Canary Medical Inc. |  |  | 2,500 |  |  |  | 34 |
Castle Creek Biosciences |  |  | 4,000 |  |  |  | 72 |
Ceribell, Inc. |  |  | 2,500 |  |  |  | 4 |
Divergent Technologies, Inc. |  |  | 30,000 |  |  |  | 315 |
DropOff, Inc. |  |  | 7,500 |  |  |  | 188 |
Embody, Inc. |  |  | 2,000 |  |  |  | 20 |
Engage3, LLC |  |  | 8,000 |  |  |  | 40 |
Hound Labs, Inc. |  |  | 7,500 |  |  |  | 87 |
Interior Define, Inc. |  |  | 5,000 |  |  |  | 65 |
KSQ Therapeutics, Inc. |  |  | 10,000 |  |  |  | 100 |
Lytics, Inc. |  |  | 1,250 |  |  |  | — |
Magnolia Medical Technologies, Inc. |  |  | 10,000 |  |  |  | 122 |
Native Microbials, Inc. |  |  | 8,750 |  |  |  | 64 |
Optoro, Inc. |  |  | 15,000 |  |  |  | 38 |
PDS Biotechnology Corporation |  |  | 10,000 |  |  |  | 158 |
Scientia Vascular, Inc. |  |  | 10,000 |  |  |  | 110 |
Slingshot Aerospace, Inc. |  |  | 5,000 |  |  |  | 64 |
Soli, Inc. |  |  | 7,500 |  |  |  | 147 |
Sonex Health, Inc. |  |  | 2,500 |  |  |  | 45 |
Swift Health Systems Inc. |  |  | 25,500 |  |  |  | 105 |
Temperpack Technologies, Inc. |  |  | 9,000 |  |  |  | 19 |
Total |  | $ | 214,500 |  |  | $ | 2,147 |

X
- Definition Tabular disclosure of the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined) which are not recognized in the financial statements (off-balance sheet) because they fail to meet some other criterion for recognition. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 11 -URI https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611 + Details
Name: | us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_TableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration